HS Icon Blood, antisera, vaccines, toxins and cultures in  Flag Canada

2019
Exports | Imports
: $684M | $4.87B, World Rnk 21 / 201
Flag Rnk 102 / 1208 | World Rnk 11 / 222
Flag Rnk 13 / 1213

2018 - 2019
FASTEST GROWING MARKET | FASTEST GROWING ORIGIN
: $5.51M | $133M, France |  Switzerland

2019
ECONOMIC COMPLEXITY of Canada
: 0.96, Rnk 31 / 147

2019
PRODUCT COMPLEXITY  IN Blood, antisera, vaccines, toxins and cultures
: 1.19, Rnk 110 / 1029

Exports In 2019, Canada exported $684M in Blood, antisera, vaccines, toxins and cultures, making it the 21st largest exporter of Blood, antisera, vaccines, toxins and cultures in the world. At the same year, Blood, antisera, vaccines, toxins and cultures was the 102nd most exported product in Canada. The main destination of Blood, antisera, vaccines, toxins and cultures exports from Canada are: United States ($486M), France ($42.4M), Belgium ($21M), South Korea ($17.2M), and United Kingdom ($13.4M).

The fastest growing export markets for Blood, antisera, vaccines, toxins and cultures of Canada between 2018 and 2019 were France ($5.51M), Hungary ($1.87M), and United Kingdom ($1.85M).

Imports In 2019, Canada imported $4.87B in Blood, antisera, vaccines, toxins and cultures, becoming the 11th largest importer of Blood, antisera, vaccines, toxins and cultures in the world. At the same year, Blood, antisera, vaccines, toxins and cultures was the 13th most imported product in Canada. Canada imports Blood, antisera, vaccines, toxins and cultures primarily from: Switzerland ($1.56B), United States ($1.36B), Germany ($565M), Ireland ($389M), and Belgium ($345M).

The fastest growing import markets in Blood, antisera, vaccines, toxins and cultures for Canada between 2018 and 2019 were Switzerland ($133M), Germany ($117M), and Belgium ($99.6M).

June 2021

Subnational Monthly Trade

#permalink to section
Time Scale
Flow
Value

EXPORT GROWTH (June 2020 - June 2021): C$-848k, (-1.38%)

IMPORT GROWTH (June 2020 - June 2021): C$865M, (219%)

MAIN EXPORTER (June 2021): Quebec, C$35.4M

MAIN DESTINATION (June 2021): United States, C$29.3M

This section shows Blood, antisera, vaccines, toxins and cultures's exports and imports data at subnational level for Canada. Click any date in the line plot, any subnational region in the geomap, or any destination or origin country to explore the exports or imports behavior of Blood, antisera, vaccines, toxins and cultures over time.

For full datasets download visit Bulk Download page.

Go to Bulk Download

Historical Data

#permalink to section
Value
Compare to

EXPORTS (2019): $684M

IMPORTS (2019): $4.87B

NET TRADE (2019): -$4.19B

In 2019, Canada exported $684M in Blood, antisera, vaccines, toxins and cultures. The main destinations of Canada exports on Blood, antisera, vaccines, toxins and cultures were United States ($486M), France ($42.4M), Belgium ($21M), South Korea ($17.2M), and United Kingdom ($13.4M).

In 2019, Canada imported $4.87B in Blood, antisera, vaccines, toxins and cultures, mainly from Switzerland ($1.56B), United States ($1.36B), Germany ($565M), Ireland ($389M), and Belgium ($345M).

Explore Visualizations

IN 2019, Canada HAD A POSITIVE NET TRADE IN Blood, antisera, vaccines, toxins and cultures WITH:

IN 2019, Canada HAD A NEGATIVE NET TRADE IN Blood, antisera, vaccines, toxins and cultures WITH:

Flow

THE FASTEST GROWING Blood, antisera, vaccines, toxins and cultures EXPORT MARKETS FOR Canada WERE (2018 - 2019):

THE FASTEST DECLINING MARKETS FOR THE EXPORT OF Blood, antisera, vaccines, toxins and cultures BY Canada WERE (2018 - 2019):

Explore Visualizations

Market Concentration

#permalink to section
Flow
Type

In 2019, Canada's main exporting competitors in Blood, antisera, vaccines, toxins and cultures were:

In 2019, Canada's main importing competitors in Blood, antisera, vaccines, toxins and cultures were:

Explore Visualizations

Tariffs by Country

#permalink to section

In 2018, the tariffs for Blood, antisera, vaccines, toxins and cultures in the imports of Canada were of 0% around the world.